MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer

Oncogene ◽  
2019 ◽  
Vol 39 (4) ◽  
pp. 862-876 ◽  
Author(s):  
Chia-Hao Tung ◽  
Li-Wei Kuo ◽  
Meng-Fan Huang ◽  
Yi-Ying Wu ◽  
Yao-Tsung Tsai ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cell Motility ◽  
Prognostic Biomarker ◽  
Recurrent Ovarian Cancer

Abstract 2235: Circulating microRNA-205 as a potential prognostic biomarker for recurrent ovarian cancer

2019 ◽  
Author(s):  
Meghan W. Kusch ◽  
Julia A. Chapman ◽  
Carl P. Weiner ◽  
Katherine F. Roby ◽  
Dineo Khabele ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Prognostic Biomarker ◽  
Recurrent Ovarian Cancer ◽  
Circulating Microrna

Resource Utilization and Expenditures During the “Watchful Waiting” Period in Patients With Recurrent Ovarian Cancer

2019 ◽  
Vol 5 (1) ◽  
pp. 40-48 ◽  
Author(s):  
Brooke Harrow ◽  
Karin Travers ◽  
Brian M Davis ◽  
Paula Smith ◽  
Adrienne M Gilligan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Resource Utilization ◽  
Watchful Waiting ◽  
Recurrent Ovarian Cancer ◽  
Waiting Period

ROLE OF ULTRASOUND IN THE DETECTION OF RECURRENT OVARIAN CANCER

2020 ◽  
Vol 6 (1) ◽  
pp. 23-31
Author(s):  
M. Alisherova ◽  
◽  
M. Ismailova
Keyword(s):  
Ovarian Cancer ◽  
Surgical Treatment ◽  
Reproductive System ◽  
Malignant Tumors ◽  
Recurrent Ovarian Cancer ◽  
Primary Diagnosis ◽  
Female Reproductive System

Currently, there are no standard approaches to monitoring patients with ovarian cancer (OC). While the role of ultrasound (US) has been identified in the primary diagnosis of OS, it is still controversial during the subsequent surgical treatment of OC. In world statistics, ovarian cancer is consistently among the four main localizations of malignant tumors of the female reproductive system, along with tumors of the breast, body and cervix.

Sign in / Sign up

Export Citation Format

Share Document